JAK2 and myeloproliferative neoplasm: Since JAK2 mutations in MPN are accompanied by an activated JAK/STAT signaling [3], two human MPN cell lines with known JAK2 V617F mutation were analyzed for the expression and activity of IFN-γ signaling components.